Citation

Barlaam B, Anderton J, Ballard P, Bradbury RH, Hennequin LF, Hickinson DM, Kettle JG, Kirk G, Klinowska T, Lambert-van der Brempt C, Trigwell C, Vincent J, Ogilvie D.: Discovery of AZD8931, an Equipotent, Reversible Inhibitor of Signaling by EGFR, HER2, and HER3 Receptors. ACS Med Chem Lett, Volume 4 (8), 2013

Authors

Anderton J, Ballard P, Barlaam B, Bradbury RH, Hennequin LF, Hickinson DM, Kettle JG, Kirk G, Klinowska T, Lambert-van der Brempt C, Ogilvie D., Trigwell C, Vincent J

Journal

ACS Med Chem Lett

Year

2013

DOI

10.1021/ml400146c

PubMed

24900741

Machine-readable

REST APIRDF